Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy

American Journal of the Medical Sciences

Volumn 332, Issue 6, 2006, Pages 361-363

  Yamada, Takahisa ^a   Node, Koichi ^b   Mine, Takanao ^a   Morita, Takashi ^a   Kioka, Hidetaka ^a   Tamaki, Shunsuke ^a   Tsukamoto, Yasumasa ^a   Masuda, Masaharu ^a   Okuda, Keiji ^a   Fukunami, Masatake ^a  

^a OSAKA GENERAL MEDICAL CENTER   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Cardiac function; Heart failure; Left ventricular remodeling; Statin

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; METOPROLOL; OXYGEN; PIMOBENDAN; PLACEBO;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; COUGHING; HEART FAILURE; HEART FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MALE; OXYGEN CONSUMPTION;

ADULT; ANTICHOLESTEREMIC AGENTS; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR AGENTS; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PYRROLES; VENTRICULAR REMODELING;

EID: 33845764761     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200612000-00011     Document Type: Article

References (15)

1. Krum H, McMurray JJ. Statins and chronic heart failure: do we need a large-scale outcome trial? J Am Coll Cardiol 2002;39:1567-73.
2. Horowich TB, MacLellan WR, Fonarow GC. Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure. J Am Coll Cardiol 2004;43:642-8.
3. Mozaffarian D, Nye R, Levy WC. Statin therapy is associated with lower mortality among patients with severe heart failure. Am J Cardiol 2004;93:1124-9.
4. Ray JG, Gong Y, Sykora K, et al. Statin use and survival outcomes in elderly patients with heart failure. Arch Intern Med 2005;165:62-7.
5. Node K, Fujita M, Kitakaze M, et al. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108:839-43.
6. Laufs U, Wassermann S, Schackmann S, et al. Beneficial effects of statins in patients with non-ischemic heart failure. Z Karilol 2004;93:103-8.
7. Sola S, Mir MQS, Rajagopalan S, et al. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure. J Cardiac Failure 2005;11:602-12.
8. Effects of Pimobendan on Chronic Heart Failure Study (EPOCH Study). Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study). Circ J 2002;66:149-57.
9. Yamada T, Simonagata T, Fukunami M, et al. Comparison of the prognostic value of cardiac Iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure. J Am Coll Cardiol 2003;41:231-8.
10. Wilson SH, Simari RD, Best PJM, et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Artherioscler Thromb Vasc Biol 2001;21:122-8.
11. Pliquett RU, Cornish KG, Zucker IH. Statin therapy restores sympathovagal balance in experimental heart failure. J Appl Physiol 2003;95:700-4.
12. Hayashidani S, Tsutsui H, Shiomi T, et al. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002;105:868-73.
13. Jialal I, Stein D, Balis D, et al. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation 2001;103:1933-5.
14. Corsini A, Pazzucconi F, Arnaboldi L, et al. Direct effects on statins on the vascular wall. J Cardiovasc Pharmacol 1998;31:773-8.
15. Bellosta S, Bernini F, Ferri N, et al. Pleiotropic effects of statins in atherosclerosis and diabetes. Diabetes Care 2000;23:B72-8.